Po-Huang Liang

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Venues

Antimicrobial agents and chemotherapy

ACS omega

FEBS letters

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Wen-Fang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, Jia-Rong Jheng, Chung-Fan Hsieh, Yuan-Fan Chin, Tein-Yao Chang, Jin-Ching Lee, Po-Huang Liang, Chia-Yi Lin, Guan-Hua Lin, Jie-Yun Cai, Yu-Li Chen, Yuan-Siao Chen, Shan-Ko Tsai, Ping-Cheng Liu, Chuen-Mi Yang, Tolou Shadbahr, Jing Tang, Yu-Lin Hsu, Chih-Heng Huang, Ling-Yu Wang, Cheng Cheung Chen, Jyh-Hwa Kau, Yi-Jen Hung, Hsin-Yi Lee, Wen-Chieh Wang, Hui-Ping Tsai, Jim-Tong Horng
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir. Antimicrobial agents and chemotherapy 68 (4) (2024)
Chen-Wei Li, Tai-Ling Chao, Chin-Lan Lai, Cheng-Chin Lin, Max Yu-Chen Pan, Chieh-Ling Cheng, Chih-Jung Kuo, Lily Hui-Ching Wang, Sui-Yuan Chang, Po-Huang Liang
Systematic Studies on the Anti-SARS-CoV-2 Mechanisms of Tea Polyphenol-Related Natural Products. ACS omega 9 (22) (2024)
Wen-Fang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, Jia-Rong Jheng, Chung-Fan Hsieh, Yuan-Fan Chin, Tein-Yao Chang, Jin-Ching Lee, Po-Huang Liang, Chia-Yi Lin, Guan-Hua Lin, Jie-Yun Cai, Yu-Li Chen, Yuan-Siao Chen, Shan-Ko Tsai, Ping-Cheng Liu, Chuen-Mi Yang, Tolou Shadbahr, Jing Tang, Yu-Lin Hsu, Chih-Heng Huang, Ling-Yu Wang, Cheng Cheung Chen, Jyh-Hwa Kau, Yi-Jen Hung, Hsin-Yi Lee, Wen-Chieh Wang, Hui-Ping Tsai, Jim-Tong Horng
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir. Antimicrobial agents and chemotherapy 68 (4) (2024)
Chen-Wei Li, Tai-Ling Chao, Chin-Lan Lai, Cheng-Chin Lin, Max Yu-Chen Pan, Chieh-Ling Cheng, Chih-Jung Kuo, Lily Hui-Ching Wang, Sui-Yuan Chang, Po-Huang Liang
Systematic Studies on the Anti-SARS-CoV-2 Mechanisms of Tea Polyphenol-Related Natural Products. ACS omega 9 (22) (2024)
Wen-Fang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, Jia-Rong Jheng, Chung-Fan Hsieh, Yuan-Fan Chin, Tein-Yao Chang, Jin-Ching Lee, Po-Huang Liang, Chia-Yi Lin, Guan-Hua Lin, Jie-Yun Cai, Yu-Li Chen, Yuan-Siao Chen, Shan-Ko Tsai, Ping-Cheng Liu, Chuen-Mi Yang, Tolou Shadbahr, Jing Tang, Yu-Lin Hsu, Chih-Heng Huang, Ling-Yu Wang, Cheng Cheung Chen, Jyh-Hwa Kau, Yi-Jen Hung, Hsin-Yi Lee, Wen-Chieh Wang, Hui-Ping Tsai, Jim-Tong Horng
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir. Antimicrobial agents and chemotherapy (2024)
Wen-Fang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, Jia-Rong Jheng, Chung-Fan Hsieh, Yuan-Fan Chin, Tein-Yao Chang, Jin-Ching Lee, Po-Huang Liang, Chia-Yi Lin, Guan-Hua Lin, Jie-Yun Cai, Yu-Li Chen, Yuan-Siao Chen, Shan-Ko Tsai, Ping-Cheng Liu, Chuen-Mi Yang, Tolou Shadbahr, Jing Tang, Yu-Lin Hsu, Chih-Heng Huang, Ling-Yu Wang, Cheng Cheung Chen, Jyh-Hwa Kau, Yi-Jen Hung, Hsin-Yi Lee, Wen-Chieh Wang, Hui-Ping Tsai, Jim-Tong Horng
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir. Antimicrobial agents and chemotherapy 68 (4) (2024)
Wen-Fang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, Jia-Rong Jheng, Chung-Fan Hsieh, Yuan-Fan Chin, Tein-Yao Chang, Jin-Ching Lee, Po-Huang Liang, Chia-Yi Lin, Guan-Hua Lin, Jie-Yun Cai, Yu-Li Chen, Yuan-Siao Chen, Shan-Ko Tsai, Ping-Cheng Liu, Chuen-Mi Yang, Tolou Shadbahr, Jing Tang, Yu-Lin Hsu, Chih-Heng Huang, Ling-Yu Wang, Cheng Cheung Chen, Jyh-Hwa Kau, Yi-Jen Hung, Hsin-Yi Lee, Wen-Chieh Wang, Hui-Ping Tsai, Jim-Tong Horng
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir. Antimicrobial agents and chemotherapy 68 (4) (2024)
Wen-Fang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, Jia-Rong Jheng, Chung-Fan Hsieh, Yuan-Fan Chin, Tein-Yao Chang, Jin-Ching Lee, Po-Huang Liang, Chia-Yi Lin, Guan-Hua Lin, Jie-Yun Cai, Yu-Li Chen, Yuan-Siao Chen, Shan-Ko Tsai, Ping-Cheng Liu, Chuen-Mi Yang, Tolou Shadbahr, Jing Tang, Yu-Lin Hsu, Chih-Heng Huang, Ling-Yu Wang, Cheng Cheung Chen, Jyh-Hwa Kau, Yi-Jen Hung, Hsin-Yi Lee, Wen-Chieh Wang, Hui-Ping Tsai, Jim-Tong Horng
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir. Antimicrobial agents and chemotherapy 68 (4) (2024)
Jia-Jin Liu, Po-Huang Liang
Complexation and evolution of cis-prenyltransferase homologues in Cinnamomum kanehirae deduced from kinetic and functional characterizations. Protein science : a publication of the Protein Society (2023)
Chih-Jung Kuo, Po-Huang Liang
SARS-CoV-2 3CL pro displays faster self-maturation in vitro than SARS-CoV 3CL pro due to faster C-terminal cleavage. FEBS letters 596 (9) (2022)
Pei-Chen Yu, Chen-Hao Huang, Chih-Jung Kuo, Po-Huang Liang, Lily Hui-Ching Wang, Max Yu-Chen Pan, Sui-Yuan Chang, Tai-Ling Chao, Si-Man Ieong, Jun-Tung Fang, Hsuan-Cheng Huang, Hsueh-Fen Juan
Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets. Pharmaceutics 14 (1) (2022)
Ho Sing Lo, Kenrie Pui Yan Hui, Hei-Ming Lai, Xu He, Khadija Shahed Khan, Simranjeet Kaur, Junzhe Huang, Zhongqi Li, Anthony K C Chan, Hayley Hei-Yin Cheung, Ka-Chun Ng, John Chi Wang Ho, Yu Wai Chen, Bowen Ma, Peter Man-Hin Cheung, Donghyuk Shin, Kaidao Wang, Meng-Hsuan Lee, Barbara Selisko, Cecilia Eydoux, Jean-Claude Guillemot, Bruno Canard, Kuen-Phon Wu, Po-Huang Liang, Ivan Đikić, Zhong Zuo, Francis K L Chan, David S C Hui, Vincent C T Mok, Kam-Bo Wong, Chris Ka Pun Mok, Ho Ko, Wei Shen Aik, Michael Chi Wai Chan, Billy Wai-Lung Ng
Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir. ACS central science 7 (5) (2021)
Chih-Jung Kuo, Tai-Ling Chao, Han-Chieh Kao, Ya-Min Tsai, Yi-Kai Liu, Lily Hui-Ching Wang, Ming-Chang Hsieh, Sui-Yuan Chang, Po-Huang Liang
Kinetic Characterization and Inhibitor Screening for the Proteases Leading to Identification of Drugs against SARS-CoV-2. Antimicrobial agents and chemotherapy 65 (4) (2021)
Yun-Xun Chang, Yuan-Feng Lin, Chi-Long Chen, Ming-Shyan Huang, Michael Hsiao, Po-Huang Liang
Chaperonin-Containing TCP-1 Promotes Cancer Chemoresistance and Metastasis through the AKT-GSK3β-β-Catenin and XIAP-Survivin Pathways. Cancers 12 (12) (2020)
Nikhil Pathak, Yun-Ti Chen, Yen-Chao Hsu, Nung-Yu Hsu, Chih-Jung Kuo, Hui Ping Tsai, Jaw-Jou Kang, Chih-Heng Huang, Sui-Yuan Chang, Yu-Hsiu Chang, Po-Huang Liang, Jinn-Moon Yang
Uncovering Flexible Active Site Conformations of SARS-CoV-2 3CL Proteases through Protease Pharmacophore Clusters and COVID-19 Drug Repurposing. ACS nano 15 (1) (2020)

Po-Huang Liang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Po-Huang Liang